Novozymes A/S NVZMY
64.39 USD -0.27 (-0.42%)
Regular-session close
64.29 Day range 64.98
49.90 52-week range 75.27
- YTD
- +1.21%
- 1 year
- +6.77%
Included in Essentials and up
Sign in to see Fair value
Discounted cash flow estimates against the price, and the P/E against its industry and sector.
Included in Essentials and up
Sign in to see Head count and owner earnings
Employees by annual report and the cash the business earns for its owners.
Included in Essentials and up
Sign in to see P/E against peers
The price to earnings ratio beside the closest competitors and their median.
Included in Essentials and up
Sign in to see Cash flow and returns
How profit turns into free cash flow, and the returns on equity, assets and capital.
Financial health
Altman Z-Score
24.47 Safe zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
5 / 9 Average
Nine pass/fail tests of profitability, leverage and efficiency.
Rating
C-1 / 5 overall
- DCF 1
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 3
- P/E 1
- P/B 1
Valuation
P/E 300×
P/S 40.3×
P/B 15.4×
P/FCF 223×
EV/EBITDA 137×
EV/Sales 45.7×
FCF Yield 0.4%
Profitability
Gross Margin 53.9%
Operating Margin 21.2%
Net Margin 14.0%
ROE 5.4%
ROIC 4.6%
ROA 3.6%
Growth (YoY)
Revenue 709.4%
Operating Income 33.0%
EPS (diluted) 733.3%
Free Cash Flow 13.7%
Financial Health
Current Ratio 0.7×
Quick Ratio 0.4×
Debt / Equity 2.1×
Net Debt / EBITDA 16.0×
Interest Coverage 96.6×
Dividends
Dividend Yield 0.2%
Payout Ratio 69.0%
Annual · latest fiscal year ends 2025-12-31
